Starton Therapeutics

💡 More IP news! Read about it here: startontx.com/starton-therap…

News alert 📢 read more here: startontx.com/starton-therap…

Starton Therapeutics Announces Dosing of First Patient in Phase 2a Study Evaluating STAR-LLD for the Treatment of Multiple Myeloma. Read more here: startontx.com/starton-therap…

It was great presenting at #BiotechShowcase this week! Thank you to the organizers and everyone who joined the discussion. We look forward to continuing the engaging conversations. #JPM26

Starton Therapeutics is presenting in San Francisco this January 12–14, 2026. startontx.com/starton-therap… Let’s connect at #BiotechShowcase! Secure your spot and set up one-to-one meetings here: biotechshowcase.com

We are pleased to announce that Dr. Jamie Oliver, our Chief Medical Officer, will present in an upcoming Labroots webinar sponsored by Primetech Corporation discussing The Journey From Idea to Impact on October 29, to learn more please visit: startontx.com/starton-therap…

Starton Therapeutics Announces Vice President of Research and Development/Manufacturing. Read more here: startontx.com/starton-therap…

Pedro Lichtinger, Starton's Chairman & CEO, will be participating in a panel on Driving Productivity in R&D at the Boston CEO Conference. To learn more and join the conversation please visit: longwoodhealthcareleaders.com/bostonceo #longwoodhealthcareleaders #BostonCEO

For patients & families, #BloodCancerAwareness doesn’t end in September. It’s every appointment, every treatment, every worry—and every victory. We’re committed to better treatments, because for them, it’s every day.

Today is World Cancer Research Day. Research is the key to better treatments, brighter futures, and saving lives. Today we honor those who work tirelessly to advance new treatment options in the pursuit of helping patients. #WorldCancerResearchDay #ResearchSavesLives

In the U.S., an estimated 176,400 people are living with myeloma, the second most common blood cancer. Advances in the treatments have improved remission rates, quality of life and survival. However, more work needs to be done.

Leukemia is a broad term for cancer of the blood cells, classified by the cell type and growth speed. Leukemia occurs most often in adults older than 55, but it is also the most common cancer in children younger than 15. #BeLeukemiaAware

Starton Therapeutics further expands its intellectual property portfolio surrounding lead candidate, STAR-LLD. Read more here: startontx.com/starton-therap…

There are approximately 825,651 people living with, or in remission from, lymphoma in the US. Increasing awareness of lymphoma will help people better recognize signs and symptoms, leading to earlier diagnosis and more timely treatment. #WorldLymphomaAwarenessDay

An estimated combined total of 192,000 people in the US are expected to be diagnosed with leukemia, lymphoma or myeloma in 2025. These cases account for approximately 10% of the new cancer diagnoses.

There are over 100 types of blood cancer, including some rare forms you may have never heard of. Blood cancer affects the blood cells, bone marrow, lymph nodes and other parts of the lymphatic system requiring innovative and specialized treatments. #BloodCancerAwarenessMonth

Behind every blood cancer diagnosis is a family that refuses to give up hope. At Starton, we refuse to give up hope too. This Blood Cancer Awareness Month, we’re shining a light on the fight against blood cancer. ❤️ #BloodCancerAwarenessMonth #kNOwmyeloma #letstalklymphoma

“We are excited to enter into this agreement with @Bend_Bioscience for the development of an oral sustained release formulation of STAR-LLD” said Pedro Lichtinger, Starton Therapeutics Chairman and CEO. Read more here: startontx.com/starton-therap…

We’re pleased to share that our Phase 2a clinical trial evaluating STAR-LLD in patients with multiple myeloma is now open for enrollment. This is an important step forward in our mission to develop innovative therapies for patients. Read more here: startontx.com/starton-therap…

Sunday is #NationalCancerSurvivorsDay, we honor the strength, courage, and resilience of those who face cancer. At Starton, we're advancing innovative solutions to potentially improve outcomes and quality of life. Here's to life, hope, and perseverance. #CancerAwareness